from the FDA:
FDA Approves Tykerb for Advanced Breast Cancer Patients
"The Food and Drug Administration (FDA) today approved Tykerb (lapatinib), a new targeted anti-cancer treatment, to be used in combination with capectabine (Xeloda), another cancer drug, for patients with advanced, metastatic breast cancer that is HER2 positive (tumors that exhibit HER2 protein)."
from the International Agency on Research for Cancer:
Sunbed use in youth unequivocally associated with skin cancer
"Melanoma is on the increase everywhere in the world and the number of cases doubles every 12-15 years in the most affected areas...
The data showed a prominent and consistent increase in risk for melanoma in people who first used sunbeds in their twenties or teen years: a 75% increase in risk of melanoma was calculated for such users of artificial tanning appliances, while this increase in the general population, although not statistically significant, is still not negligible."
